logo
Plus   Neg
Share
Email

Mazda Financial Services To Offer Payment Deferral For Eligible Customers

Toyota Motor Credit Corp. said it has launched a private label business with Mazda North American Operations through the creation of Mazda Financial Services.

Mazda Financial Services will offer a payment deferral program for up to 90 days on new and Certified Used Mazda Vehicles to eligible customers who finance a new or Certified Used Mazda vehicle on or after April 1, 2020, through April 30, 2020.

In addition, the company will assist dealers by temporarily reducing rates on all floorplan lines and the interest on those lines, as well as providing a principal payment deferral option for real estate and working capital loans.

Mazda Financial Services began operations today and offers a suite of automotive finance, lease, wholesale, dealer banking, and insurance protection products and services to Mazda dealers and customers in the U.S.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT